Skip to main content

BIOLARGO INC

For the period ended Dec 31, 2023. Filed Apr 1, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Apr 1, 2024

BLGOStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BIOLARGO, INC.
Date: April 1, 2024By:/s/ Dennis P. Calvert
Dennis P. Calvert President and Chief Executive Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints, jointly and severally, Dennis P. Calvert and Joseph L. Provenzano, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Company and in the capacities and on the date indicated:

NameTitleDate
/s/ Dennis P. CalvertChairman of the Board, ChiefApril 1, 2024
Dennis P. CalvertExecutive Officer and President
/s/ Charles K. Dargan IIChief Financial OfficerApril 1, 2024
Charles K. Dargan II(principal financial officer and principal accounting officer)
/s/ Kenneth R. CodeChief Science Officer and DirectorApril 1, 2024
Kenneth R. Code
/s/ Joseph L. ProvenzanoExecutive Vice President, CorporateApril 1, 2024
Joseph L. ProvenzanoSecretary and Director
/s/ Jack B. StrommenDirectorApril 1, 2024
Jack B. Strommen
/s/ Dennis E. MarshallDirectorApril 1, 2024
Dennis E. Marshall
/s/ Linda ParkDirectorApril 1, 2024
Linda Park
/s/Christina BrayDirectorApril 1, 2024
Christina Bray
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.